Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)

NCT02425592 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02425592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02425592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)
Lead sponsor
Yale University
Phase
Observational
Overall status
Completed
Start date
April 30, 2015
Completion date
May 31, 2025
Enrollment
223 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer